elevidys - Search News

News

Sarepta, Elevidys and gene therapy

Sarepta resumes shipping of gene therapy Elevidys to patients who can walk

Sarepta Therapeutics said on Monday it will resume shipping of its muscular disorder gene therapy to patients who can walk, sending the company's shares 59% higher in extended trading. The announcement came immediately after the U.

MIT Technology Review · 3d

The deadly saga of the controversial gene therapy Elevidys

· 8h · on MSN

FDA Says Sarepta Can Resume Gene Therapy in Some Patients

3don MSN

FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy

The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received ...

Sarepta Therapeutics to Lift Pause on Shipments of Duchenne Treatment Elevidys

Sarepta Therapeutics said the Food and Drug Administration informed the company it can lift a voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne. The company said Monday ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Sarepta, Elevidys and gene therapy

Trending now